Status:
NOT_YET_RECRUITING
Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)
Lead Sponsor:
QHSLab, Inc.
Conditions:
Allergic Rhinitis
Sinusitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to evaluate the effectiveness of digital tools in managing allergic rhinitis (AR) in primary care settings. AR is a common condition that affects many people's quality of life. The stu...
Detailed Description
This clinical trial is designed to assess the impact of integrating digital medicine tools on the management of allergic rhinitis (AR) in primary care settings. The study will compare outcomes between...
Eligibility Criteria
Inclusion
- Adults aged 18-65 years.
- Clinically diagnosed with allergic rhinitis and/or sinusitis for at least 6 months.
- SNOT-22 score of ≥20, indicating uncontrolled allergic rhinitis.
- If Currently receiving treatment for allergic rhinitis and willing to continue treatment during the study.
- Able and willing to provide informed consent electronically and comply with the study procedures.
Exclusion
- Individuals under 18 or over 65 years of age.
- Pregnant or breastfeeding women.
- Recent surgical treatment for nasal polyps (within the last 3 months).
- Patients with cystic fibrosis, purulent nasal infections, or any other disease likely to interfere with the study parameters.
- Individuals with severe or unstable concurrent diseases or psychological disorders that may compromise participation in the study.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06603935
Start Date
October 1 2024
End Date
January 30 2026
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QHSLab
West Palm Beach, Florida, United States, 33407